Ledet EM - Search Results

1

Dissecting Microbiome-Derived SCFAs in Prostate Cancer: Analyzing Gut Microbiota, Racial Disparities, and Epigenetic Mechanisms.

Miya TV, Marima R, Damane BP, Ledet EM, Dlamini Z. Miya TV, et al. Among authors: ledet em. Cancers (Basel). 2023 Aug 14;15(16):4086. doi: 10.3390/cancers15164086. Cancers (Basel). 2023. PMID: 37627114 Free PMC article. Review.

2

HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG).

Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM, Zuhlke KA, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Maier C, Luedeke M, Vogel W, Schleutker J, Wahlfors T, Tammela T, Schaid D, McDonnell SK, DeRycke MS, Cancel-Tassin G, Cussenot O, Wiklund F, Grönberg H, Eeles R, Easton D, Kote-Jarai Z, Whittemore AS, Hsieh CL, Giles GG, Hopper JL, Severi G, Catalona WJ, Mandal D, Ledet E, Foulkes WD, Hamel N, Mahle L, Moller P, Powell I, Bailey-Wilson JE, Carpten JD, Seminara D, Cooney KA, Isaacs WB; International Consortium for Prostate Cancer Genetics. Xu J, et al. Among authors: ledet e. Hum Genet. 2013 Jan;132(1):5-14. doi: 10.1007/s00439-012-1229-4. Epub 2012 Oct 12. Hum Genet. 2013. PMID: 23064873 Free PMC article.

3

Androgen receptor splice variants circumvent AR blockade by microtubule-targeting agents.

Zhang G, Liu X, Li J, Ledet E, Alvarez X, Qi Y, Fu X, Sartor O, Dong Y, Zhang H. Zhang G, et al. Oncotarget. 2015 Sep 15;6(27):23358-71. doi: 10.18632/oncotarget.4396. Oncotarget. 2015. PMID: 26160840 Free PMC article.

4

Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients.

Sabol RA, Ledet EM, Jaeger E, Hatton W, Moses M, Lankford A, Zaheria A, Barata P, Layton JL, Lewis BE, Sartor O. Sabol RA, et al. Among authors: ledet em. Prostate. 2021 May;81(7):427-432. doi: 10.1002/pros.24120. Epub 2021 Mar 24. Prostate. 2021. PMID: 33760238

5

Alternative Digit Ratios and Their Relationship to Prostate Cancer.

Stolten M, Ledet E, Dotiwala A, Luk E, Sartor O. Stolten M, et al. Clin Genitourin Cancer. 2016 Apr;14(2):149-52. doi: 10.1016/j.clgc.2015.11.005. Epub 2015 Nov 12. Clin Genitourin Cancer. 2016. PMID: 26684813

6

Evaluation of the genomic alterations in the androgen receptor gene during treatment with high-dose testosterone for metastatic castrate-resistant prostate cancer.

Moses M, Koksal U, Ledet E, Manogue C, Cotogno P, Lewis B, Layton J, Sartor AO, Barata P. Moses M, et al. Oncotarget. 2020 Jan 7;11(1):15-21. doi: 10.18632/oncotarget.27408. eCollection 2020 Jan 7. Oncotarget. 2020. PMID: 32002120 Free PMC article.

7

Letter to the Editor: "Family history and pathogenic/likely pathogenic germline variants in prostate cancer patients".

Ledet EM, Sartor O. Ledet EM, et al. Prostate. 2021 Nov;81(15):1262-1263. doi: 10.1002/pros.24221. Epub 2021 Aug 31. Prostate. 2021. PMID: 34464469 No abstract available.

8

Long-Term Disease Control Using Taxane/Platinum-Based Chemotherapy in CDK12-Mutated Advanced Prostate Cancer.

Barata P, Ledet E, Manogue C, Cotogno P, Harris K, Lewis B, Layton J, Sartor O. Barata P, et al. Oncologist. 2020 Sep;25(9):e1421-e1422. doi: 10.1634/theoncologist.2020-0260. Epub 2020 Jul 12. Oncologist. 2020. PMID: 32592623 Free PMC article. No abstract available.

9

TP53 Gain-of-Function Mutations in Circulating Tumor DNA in Men With Metastatic Castration-Resistant Prostate Cancer.

Chapman L, Ledet EM, Barata PC, Cotogno P, Manogue C, Moses M, Christensen BR, Steinwald P, Ranasinghe L, Layton JL, Lewis BE, Sartor O. Chapman L, et al. Among authors: ledet em. Clin Genitourin Cancer. 2020 Apr;18(2):148-154. doi: 10.1016/j.clgc.2019.10.022. Epub 2019 Nov 6. Clin Genitourin Cancer. 2020. PMID: 31822380

10

Clinical and Genetic Analysis of Metastatic Prostate Cancer to the Central Nervous System: A Single-Institution Retrospective Experience.

Jang A, Jaeger EB, Ledet EM, Xie J, Lewis BE, Layton JL, Sartor O, Barata PC, Trevino CR. Jang A, et al. Among authors: ledet em. Clin Genitourin Cancer. 2023 Apr;21(2):e9-e18. doi: 10.1016/j.clgc.2022.10.007. Epub 2022 Oct 20. Clin Genitourin Cancer. 2023. PMID: 36376168

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

57 results

Search Page